Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.

Koyama N, Iwai Y, Nagai Y, Aoshiba K, Nakamura H.

PLoS One. 2019 Aug 23;14(8):e0221718. doi: 10.1371/journal.pone.0221718. eCollection 2019.

2.

Varicella Zoster Virus Encephalitis Mimicking Nivolumab-Induced Autoimmune Neuropathy in a Patient with Lung Cancer.

Watanabe Y, Kikuchi R, Iwai Y, Ito M, Tsukamoto H, Yamazaki K, Nakamura H, Aoshiba K.

J Thorac Oncol. 2019 Aug;14(8):e163-e165. doi: 10.1016/j.jtho.2019.02.033. No abstract available.

PMID:
31345336
3.

Acute respiratory failure due to eosinophilic pneumonia following pneumococcal vaccination.

Kikuchi R, Iwai Y, Watanabe Y, Nakamura H, Aoshiba K.

Hum Vaccin Immunother. 2019;15(12):2914-2916. doi: 10.1080/21645515.2019.1631134. Epub 2019 Jun 26.

PMID:
31184980
4.
5.

Hypercapnic tumor microenvironment confers chemoresistance to lung cancer cells by reprogramming mitochondrial metabolism in vitro.

Kikuchi R, Iwai Y, Tsuji T, Watanabe Y, Koyama N, Yamaguchi K, Nakamura H, Aoshiba K.

Free Radic Biol Med. 2019 Apr;134:200-214. doi: 10.1016/j.freeradbiomed.2019.01.014. Epub 2019 Jan 10.

PMID:
30639568
6.

Sitagliptin-induced diffuse alveolar hemorrhage mimicking pulmonary edema.

Kikuchi R, Nakamura H, Aoshiba K.

J Family Med Prim Care. 2018 Mar-Apr;7(2):480-481. doi: 10.4103/jfmpc.jfmpc_160_17. No abstract available.

7.

Simultaneous measurement of pulmonary diffusing capacity for carbon monoxide and nitric oxide.

Yamaguchi K, Tsuji T, Aoshiba K, Nakamura H.

Respir Investig. 2018 Mar;56(2):100-110. doi: 10.1016/j.resinv.2017.12.006. Epub 2018 Feb 2. Review.

PMID:
29548647
8.

Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion.

Koyama N, Watanabe Y, Iwai Y, Miwa C, Nagai Y, Aoshiba K, Nakamura H.

Neoplasma. 2018;65(1):132-139. doi: 10.4149/neo_2018_170206N78.

PMID:
29322797
9.

Lung injury associated with electronic cigarettes inhalation diagnosed by transbronchial lung biopsy.

Itoh M, Aoshiba K, Herai Y, Nakamura H, Takemura T.

Respirol Case Rep. 2017 Nov 17;6(1):e00282. doi: 10.1002/rcr2.282. eCollection 2018 Jan.

10.

Hypercapnia Accelerates Adipogenesis: A Novel Role of High CO2 in Exacerbating Obesity.

Kikuchi R, Tsuji T, Watanabe O, Yamaguchi K, Furukawa K, Nakamura H, Aoshiba K.

Am J Respir Cell Mol Biol. 2017 Nov;57(5):570-580. doi: 10.1165/rcmb.2016-0278OC.

PMID:
28613919
11.

Improvement of metabolic disorders by an EP2 receptor agonist via restoration of the subcutaneous adipose tissue in pulmonary emphysema.

Tsuji T, Yamaguchi K, Kikuchi R, Nakamura H, Misaka R, Nagai A, Aoshiba K.

Prostaglandins Other Lipid Mediat. 2017 May;130:16-22. doi: 10.1016/j.prostaglandins.2017.03.001. Epub 2017 Mar 2.

PMID:
28263859
12.

Hypertrophic Osteoarthropathy Secondary to Lung Cancer: Beneficial Effect of Anti-vascular Endothelial Growth Factor Antibody.

Kikuchi R, Itoh M, Tamamushi M, Nakamura H, Aoshiba K.

J Clin Rheumatol. 2017 Jan;23(1):47-50. doi: 10.1097/RHU.0000000000000441. No abstract available.

PMID:
28002159
13.

Little evidence for epithelial-mesenchymal transition in a murine model of airway fibrosis induced by repeated naphthalene exposure.

Watanabe O, Tsuji T, Kikuchi R, Itoh M, Nakamura H, Aoshiba K.

Exp Toxicol Pathol. 2016 Oct;68(9):517-520. doi: 10.1016/j.etp.2016.07.007. Epub 2016 Aug 4.

PMID:
27498952
14.

Successful desensitization therapy involving fluoroquinolone for the treatment of a solitary tuberculoma: A case report and literature review.

Watanabe H, Uruma T, Seita I, Chikasawa Y, Kikuchi R, Itoh M, Aoshiba K, Nakamura H, Oishi T.

Mol Clin Oncol. 2016 Jul;5(1):117-120. Epub 2016 Apr 28.

15.

Effects of extrathoracic mechanical ventilation on pulmonary hypertension secondary to lung disease.

Sato Y, Saeki N, Asakura T, Aoshiba K, Kotani T.

J Anesth. 2016 Aug;30(4):663-70. doi: 10.1007/s00540-016-2172-7. Epub 2016 Apr 18.

16.

Salivary Gland Enlargement as an Unusual Imaging Manifestation of Granulomatosis With Polyangiitis Involving the Head and Neck Region.

Kikuchi R, Aoshiba K, Nakamura H.

AJR Am J Roentgenol. 2016 Jun;206(6):W94. doi: 10.2214/AJR.16.16042. Epub 2016 Mar 21. No abstract available.

PMID:
26998726
17.

Remission of ALK-negative primary pulmonary inflammatory myofibroblastic tumor on treatment with clarithromycin: A case report and review of the literature.

Watanabe H, Uruma T, Tazaki G, Tajiri T, Kikuchi R, Itoh M, Aoshiba K, Nakamura H.

Oncol Lett. 2016 Mar;11(3):1757-1761. Epub 2016 Jan 15.

18.

Nicotine enhances hepatocyte growth factor-mediated lung cancer cell migration by activating the α7 nicotine acetylcholine receptor and phosphoinositide kinase-3-dependent pathway.

Yoneyama R, Aoshiba K, Furukawa K, Saito M, Kataba H, Nakamura H, Ikeda N.

Oncol Lett. 2016 Jan;11(1):673-677. Epub 2015 Nov 17.

19.

Soluble intercellular adhesion molecule-1 for stable and acute phases of idiopathic pulmonary fibrosis.

Okuda R, Matsushima H, Aoshiba K, Oba T, Kawabe R, Honda K, Amano M.

Springerplus. 2015 Oct 31;4:657. doi: 10.1186/s40064-015-1455-z. eCollection 2015.

20.

Diffuse alveolar hemorrhage after use of a fluoropolymer-based waterproofing spray.

Kikuchi R, Itoh M, Uruma T, Tsuji T, Watanabe H, Nakamura H, Aoshiba K.

Springerplus. 2015 Jun 17;4:270. doi: 10.1186/s40064-015-1079-3. eCollection 2015.

21.

Repeated exposure to 5-bromo-2'-deoxyuridine causes decreased proliferation and low-grade inflammation in the lungs of mice.

Tsuji T, Itoh M, Kikuchi R, Uruma T, Watanabe H, Yamaguchi K, Nakamura H, Aoshiba K.

Exp Toxicol Pathol. 2015 May-Jun;67(5-6):355-60. doi: 10.1016/j.etp.2015.04.003. Epub 2015 Apr 21.

PMID:
25911309
22.

An evolutionary medicine approach to understanding factors that contribute to chronic obstructive pulmonary disease.

Aoshiba K, Tsuji T, Itoh M, Yamaguchi K, Nakamura H.

Respiration. 2015;89(3):243-52. doi: 10.1159/000369861. Epub 2015 Feb 10. Review.

23.

All-in-one imaging of polymyositis, lung cancer and its metastatic lesions by fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography.

Itoh M, Kikuchi R, Uruma T, Tsuji T, Kuroda Y, Watanabe H, Nakamura H, Aoshiba K.

Acta Reumatol Port. 2014 Jul-Sep;39(3):283-4. No abstract available.

24.

A large cohort study concerning age-dependent impacts of anthropometric variables on spirometric parameters in nonsmoking healthy adults.

Omori H, Onoue A, Katoh T, Ogata Y, Kawashima H, Miyao N, Tsuji T, Aoshiba K, Nagai A, Yamaguchi K.

PLoS One. 2014 Jun 23;9(6):e100733. doi: 10.1371/journal.pone.0100733. eCollection 2014.

25.

Systemic effects of acute cigarette smoke exposure in mice.

Itoh M, Tsuji T, Nakamura H, Yamaguchi K, Fuchikami J, Takahashi M, Morozumi Y, Aoshiba K.

Inhal Toxicol. 2014 Jul;26(8):464-73. doi: 10.3109/08958378.2014.917346. Epub 2014 Jun 16.

PMID:
24932561
26.

Promotion of adipogenesis by an EP2 receptor agonist via stimulation of angiogenesis in pulmonary emphysema.

Tsuji T, Yamaguchi K, Kikuchi R, Itoh M, Nakamura H, Nagai A, Aoshiba K.

Prostaglandins Other Lipid Mediat. 2014 Aug;112:9-15. doi: 10.1016/j.prostaglandins.2014.05.003. Epub 2014 Jun 6.

PMID:
24911647
27.

The role of Mycoplasma pneumoniae infection in the initial onset and exacerbations of asthma.

Watanabe H, Uruma T, Nakamura H, Aoshiba K.

Allergy Asthma Proc. 2014 May-Jun;35(3):204-10. doi: 10.2500/aap.2014.35.3742. Review.

PMID:
24801462
28.

Gender-specific impacts of apnea, age, and BMI on parasympathetic nerve dysfunction during sleep in patients with obstructive sleep apnea.

Yamaguchi K, Inoue Y, Ohki N, Satoya N, Inoue F, Maeda Y, Sekiguchi H, Suzuki M, Tsuji T, Aoshiba K, Nagai A.

PLoS One. 2014 Mar 25;9(3):e92808. doi: 10.1371/journal.pone.0092808. eCollection 2014.

29.

A murine model of airway fibrosis induced by repeated naphthalene exposure.

Aoshiba K, Tsuji T, Itoh M, Semba S, Yamaguchi K, Nakamura H, Watanabe H.

Exp Toxicol Pathol. 2014 Jul;66(4):169-77. doi: 10.1016/j.etp.2014.01.001. Epub 2014 Jan 28.

PMID:
24480153
30.

Estimation of parasympathetic nerve function during sleep in patients with obstructive sleep apnea by instantaneous time-frequency analysis.

Yamaguchi K, Ohki N, Kobayashi M, Satoya N, Inoue Y, Onizawa S, Maeda Y, Sekiguchi H, Suzuki M, Tsuji T, Aoshiba K, Nagai A.

Sleep Med. 2014 Jan;15(1):33-41. doi: 10.1016/j.sleep.2013.10.005. Epub 2013 Oct 30.

PMID:
24342227
31.

Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury.

Aoshiba K, Tsuji T, Kameyama S, Itoh M, Semba S, Yamaguchi K, Nakamura H.

Exp Toxicol Pathol. 2013 Nov;65(7-8):1053-62. doi: 10.1016/j.etp.2013.04.001. Epub 2013 May 18.

PMID:
23688655
32.

Undernutrition in patients with COPD and its treatment.

Itoh M, Tsuji T, Nemoto K, Nakamura H, Aoshiba K.

Nutrients. 2013 Apr 18;5(4):1316-35. doi: 10.3390/nu5041316. Review.

33.

Hypercapnia accelerates wound healing in endothelial cell monolayers exposed to hypoxia.

Tsuji T, Aoshiba K, Itoh M, Nakamura H, Yamaguchi K.

Open Respir Med J. 2013;7:6-12. doi: 10.2174/1874306401307010006. Epub 2013 Feb 22.

34.

Isolated pineal region metastasis from lung adenocarcinoma with obstructive hydrocephalus: a case report.

Nemoto K, Aoshiba K, Itoh M, Semba S, Tsuji T, Adachi H, Nakamura H.

J Med Case Rep. 2013 Mar 14;7:71. doi: 10.1186/1752-1947-7-71.

35.

The danger signal plus DNA damage two-hit hypothesis for chronic inflammation in COPD.

Aoshiba K, Tsuji T, Yamaguchi K, Itoh M, Nakamura H.

Eur Respir J. 2013 Dec;42(6):1689-95. doi: 10.1183/09031936.00102912. Epub 2013 Feb 8. Review.

36.

Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice.

Arimura K, Aoshiba K, Tsuji T, Tamaoki J.

Lung. 2012 Dec;190(6):613-20. doi: 10.1007/s00408-012-9414-8. Epub 2012 Sep 11.

PMID:
22965854
37.

Novel regression equations predicting lung age from varied spirometric parameters.

Yamaguchi K, Omori H, Onoue A, Katoh T, Ogata Y, Kawashima H, Onizawa S, Tsuji T, Aoshiba K, Nagai A.

Respir Physiol Neurobiol. 2012 Aug 15;183(2):108-14. doi: 10.1016/j.resp.2012.06.025. Epub 2012 Jun 28.

PMID:
22750572
38.

Superiority of PC-SOD to other anti-COPD drugs for elastase-induced emphysema and alteration in lung mechanics and respiratory function in mice.

Tanaka K, Sato K, Aoshiba K, Azuma A, Mizushima T.

Am J Physiol Lung Cell Mol Physiol. 2012 Jun 15;302(12):L1250-61. doi: 10.1152/ajplung.00019.2012. Epub 2012 Apr 13.

39.

DNA damage as a molecular link in the pathogenesis of COPD in smokers.

Aoshiba K, Zhou F, Tsuji T, Nagai A.

Eur Respir J. 2012 Jun;39(6):1368-76. doi: 10.1183/09031936.00050211. Epub 2012 Jan 20.

40.

[Roles of apoptosis, cell senescence, and DNA damage in the pathogenetic mechanism of COPD].

Aoshiba K.

Nihon Rinsho. 2011 Oct;69(10):1754-7. Japanese.

PMID:
22073568
41.

How to evaluate "spirometric" lung age--what method is approvable?

Yamaguchi K, Onizawa S, Tsuji T, Aoshiba K, Nagai A.

Respir Physiol Neurobiol. 2011 Sep 15;178(2):349-51. doi: 10.1016/j.resp.2011.06.012. Epub 2011 Jun 24.

PMID:
21722756
42.

Therapeutic effect of lecithinized superoxide dismutase on pulmonary emphysema.

Tanaka K, Tanaka Y, Miyazaki Y, Namba T, Sato K, Aoshiba K, Azuma A, Mizushima T.

J Pharmacol Exp Ther. 2011 Sep;338(3):810-8. doi: 10.1124/jpet.111.179051. Epub 2011 Jun 10.

PMID:
21665943
43.

Epithelial cell senescence impairs repair process and exacerbates inflammation after airway injury.

Zhou F, Onizawa S, Nagai A, Aoshiba K.

Respir Res. 2011 Jun 10;12:78. doi: 10.1186/1465-9921-12-78.

44.

Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease.

Tsuji T, Aoshiba K, Nagai A.

Respiration. 2010;80(1):59-70. doi: 10.1159/000268287. Epub 2009 Dec 17.

45.

Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease.

Aoshiba K, Nagai A.

Proc Am Thorac Soc. 2009 Dec 1;6(7):596-601. doi: 10.1513/pats.200904-017RM. Review.

PMID:
19934355
46.

An evolutionary perspective on chronic obstructive pulmonary disease.

Aoshiba K, Nagai A.

Am J Respir Cell Mol Biol. 2009 Nov;41(5):507-8. doi: 10.1165/rcmb.2009-0001ED. No abstract available.

PMID:
19843710
47.

A systemically administered EP2 receptor agonist stimulates pulmonary angiogenesis in a murine model of emphysema.

Tsuji T, Aoshiba K, Yokohori N, Nagai A.

Prostaglandins Other Lipid Mediat. 2009 Dec;90(3-4):85-8. doi: 10.1016/j.prostaglandins.2009.09.002. Epub 2009 Sep 16.

PMID:
19765669
48.

Therapeutic effects of erythropoietin in murine models of endotoxin shock.

Aoshiba K, Onizawa S, Tsuji T, Nagai A.

Crit Care Med. 2009 Mar;37(3):889-98. doi: 10.1097/CCM.0b013e31819b8371.

PMID:
19237893
49.

Platinum nanoparticle antioxidants inhibit pulmonary inflammation in mice exposed to cigarette smoke.

Onizawa S, Aoshiba K, Kajita M, Miyamoto Y, Nagai A.

Pulm Pharmacol Ther. 2009 Aug;22(4):340-9. doi: 10.1016/j.pupt.2008.12.015. Epub 2008 Dec 31.

PMID:
19166956
50.

Chronic lung inflammation in aging mice.

Aoshiba K, Nagai A.

FEBS Lett. 2007 Jul 24;581(18):3512-6. Epub 2007 Jul 5.

Supplemental Content

Loading ...
Support Center